Docusate Sodium capsules USP 100mg | DOCUSATE SODIUM
Docusate sodium 100 mg
Do not use
Ask a doctor before use if you have
Stop use and ask a doctor if
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
|adults and children 12 years and over||take 1-3 capsules daily|
|children 2 to under 12 years of age||take 1 capsule daily|
|children under 2 years||ask a doctor|
D&C Red No. 33, FD&C Red No. 40, FD&C Yellow No. 6, gelatin, glycerin, methylparaben, PEG 400, propylene glycol, propylparaben, sorbitol, titanium dioxide
Docusate Sodium capsules USP 100mg
Each Softgel Contains: (Docusate Sodium USP 100mg)
WARNING: KEEP OUT OF REACH OF CHILDREN
STORE CONTROLLED ROOM TEMPERATURE OF 59° – 86°F (15° – 30°C) PROTECT FROM LIGHT, MOISTURE AND FREEZING
THIS IS A BULK SHIPMENT INTENDED FOR FURTHER PROCESSING ONLY. CONTENTS SHOULD BE APPROVED, REPACKAGED IMMEDIATELY AND LABELED IN STRICT CONFORMANCE WITH THE F.D & C.ACT AND REGULATIONS THEREUNDER.
MANUFACTURED BY: SOFTGEL HEALTHCARE PVT LIMITED INDIA LABELLER CODE : 35916 LIC NO. : TN/DRUGS/00002124
MANUFACTURED FOR: SPIRIT PHARMACEUTICALS LLC 225 LINCOLN HWY, STE 205 FAIRLESS HILLS, PA 19030 PH.# 215 943 4000 FAX.# 215 943 4039
CAUTION : "FOR MANUFACTURING, PROCESSING OR REPACKING"
|DRUM NO||:||NDC NO||: 68210-0401-*|
|MFG DATE||:||EXP DATE||:|
Drugs and Medications
Surfak Stool Softener
DOCUSATE SODIUM CAPSULES USP 50 MG
Promolaxin™ Docusate Sodium Stool Softener
Docusate Sodium 100 mg
Surfak Stool Softener Original Formula
The purpose of this study is to determine if docusate is effective in the treatment of constipation in palliative care patients.
The purpose of this study is to assess the effect of a standardized postoperative bowel regimen of over-the-counter medications in subjects undergoing minimally invasive urogynecologic sur...
The loss of sodium during infancy causes long term changes in sodium intake. Human research shows that the loss of maternal sodium during pregnancy and neonatal after birth causes an incre...
OBJECTIVES: I. Assess the safety and efficacy of sodium phenylbutyrate, sodium benzoate, sodium phenylacetate, and dietary intervention in patients with urea cycle disorders.
To determine the relationship between degree of sodium restriction and dietary compliance with clinical outcome of diuresis of portal hypertensive ascites in cirrhotic patients from a coun...
Oral bioavailability of atorvastatin calcium (ATC) is very low (only 14%) due to instability and incomplete intestinal absorption and/or extensive gut wall extraction. When ATC is packed in the form o...
The LUCK study: Laxative Usage in patients with GP-diagnosed Constipation in the UK, within the general population and in pregnancy. An epidemiological study using the General Practice Research Database (GPRD).
Background: Despite the high prevalence of constipation and its related public health implications, there is relatively little research available on the condition from large epidemiological studies. T...
Phenol formation by gamma radiolysis of an aqueous benzene solution containing sodium hypochlorite is reported. The phenol formation in a benzene solution containing sodium hypochlorite irradiated wit...
Sodium balance is vital to maintaining normal physiological function. Imbalances can occur in a variety of diseases, during certain surgical operations or during rigorous exercise. There is currently...
Density functional theory and the cluster expansion method are used to model 2-10 nm sodium alanate (NaAlH(4)) nanoparticles and related decomposition products Na(3)AlH(6), NaH, and Al. While bulk sod...